1 completed. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Two dose MenACWY vaccine: new trials by email Literature Review of Two dose MenACWY vaccine trials Research Report on Two dose MenACWY vaccine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Investigating a Vaccine Against COVID-19 ChAdOx1 nCoV-19 (Abs 260), MenACWY vaccine, ChAdOx1 nCoV-19 (Abs 260) + 2.2x10^10vp (qPCR) boost - Coronavirus | Phase 2 / Phase 3 | Completed | University of Oxford | 10811 | 2020-05-28 | 2025-09-03 |
COVID-19 (1) · Coronavirus Infections (1)
United Kingdom (1)
PMID 33220855, PMID 33306989, PMID 33335323, PMID 33617777, PMID 33798499, PMID 34153264, PMID 34480858, PMID 35192543